Market Research Future (MRFR) has published a cooked research report on the “Global Blood Glucose Monitoring Market” that contains information from 2018 to 2030. The Global Blood Glucose Monitoring Market is estimated to register a CAGR of 4.45% during the forecast period of 2025 to 2035.

Blood Glucose Monitoring Market Highlights

The Global Blood Glucose Monitoring Market is accounted to register a CAGR of 4.45% during the forecast period and is estimated to reach USD 26.5 billion by 2035.

The global blood glucose monitoring market refers to the market for devices and systems used to measure and monitor blood glucose levels in individuals, particularly those with diabetes. These devices play a crucial role in managing diabetes by providing real-time information about blood sugar levels, enabling individuals to make informed decisions about their diet, medication, and lifestyle.

Key Players:

MRFR recognizes the following companies as the key players in the Global Blood Glucose Monitoring Market— Abbott Laboratories (US), Arkay, Inc. (US), Bayer Healthcare AG (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Sanofi (France), GlySure Ltd (U.K), Sphere Medical Holding plc. (UK), Dexcom, Inc. (US), and LifeScan, Inc. (US), and Novo Nordisk (Denmark)

Segment Analysis

The Global Blood Glucose Monitoring Market has been segmented based Product, Application, End User

The blood glucose monitoring market segmentation, based on product, includes self-monitoring blood glucose devices, and continuous blood glucose monitoring devices. The self-monitoring blood glucose devices segment held the majority share in 2021 in respect to the market revenue of blood glucose monitoring. This is primarily owing to  the low cost and ease of use. It is also considered an important element of diabetes management daily. Self-monitoring of blood sugar is an approach wherein people measure their blood sugar levels with the help of a glucose meter. It is sub-segmented into blood glucose meter, testing strips, and lancets.

The market segment of blood glucose monitoring, based on application, includes Type 1 diabetes, and type 2 diabetes. The type 2 diabetes segment dominated the market in 2021 in respect to the blood glucose monitoring market revenue. This is due to the increasing incidence of type 2 diabetes and increasing innovative product launches with less invasive technologies. Hence, rising incidence of type 2 diabetes will positively impacts the blood glucose monitoring market growth.

The market segment of blood glucose monitoring, based on end user, includes hospitals & clinics, diagnostic centers, and others. The hospitals and clinics held the largest market share in 2021 in respect to the blood glucose monitoring market revenue. This is owing to the improving infrastructure and increasing healthcare expenditure in hospitals and clinics. Moreover, the reliable data that blood glucose monitoring devices provide practitioners in a fraction of seconds and the improvement in patients' quality of life have increased their adoption in the outpatient as well as inpatient hospital and clinic settings.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of: Blood Glucose Monitoring Market Research Report

Regional Analysis

The Global Blood Glucose Monitoring Market, based on region, has been divided into North America, Europe, Asia-Pacific and Rest of the World. North America blood glucose monitoring held the largest market share in 2021. This is attributed to the increasing prevalence of obesity, high cost of treatment, technological advancements, and new product launches by the major players across the region. Further, the major countries studied are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Europe blood glucose monitoring market accounts for the second-largest market share due to the increase in the geriatric population, which is prone to diabetes. Moreover, improvements in the healthcare sector and the implementation of advanced medical products are augmenting the demand for blood glucose monitoring in the region. Further, the Germany market of blood glucose monitoring held the largest market share, and the UK market of blood glucose monitoring was the fastest growing market in the European region.

The Asia-Pacific market of blood glucose monitoring is expected to grow at the significant growth rate during the forecast period. This is due to the improvements in healthcare facilities and reimbursement policies in developing economies are key factors aiding the growth in this region. Moreover, China market of blood glucose monitoring held the largest market share, and the India market of blood glucose monitoring was the fastest growing market in the Asia-Pacific region. Hence, Asia-Pacific is anticipated to register the highest growth rate over the forecast period from 2022–2030.

Key Findings of the Study

• The Asia-Pacific market of blood glucose monitoring is expected to grow at the significant growth rate during the forecast period. This is due to the improvements in healthcare facilities and reimbursement policies in developing economies are key factors aiding the growth in this region.


• The blood glucose monitoring market segmentation, based on product, includes self-monitoring blood glucose devices, and continuous blood glucose monitoring devices.


• Abbott Laboratories (US), Arkay, Inc. (US), Bayer Healthcare AG (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Sanofi (France), GlySure Ltd (U.K), Sphere Medical Holding plc. (UK), Dexcom, Inc. (US), and LifeScan, Inc. (US), Novo Nordisk (Denmark)